Corneal Neovascularization
📧 Sign up to get email alerts when something new happens for Corneal Neovascularization.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-01-09Clinical Trial Update: Clinical Study of Intrastromal Anti-VEGF Injection for Corneal Neovascularization. [Phase 1, Phase 2]
A Phase 1/2 clinical study is evaluating intrastromal anti-VEGF injections to treat corneal neovascularization in patients with herpes simpl…
-
CLINICAL_TRIALS research · 2025-07-31Clinical Trial Update: Corneal Crosslinking for Treatment of Corneal Neovascularization [Phase 2, Phase 3]
This ClinicalTrials.gov entry reports that a Phase 2/Phase 3 study evaluating corneal crosslinking for treating corneal neovascularization i…
-
CLINICAL_TRIALS trial_result · 2024-08-01Clinical Trial Update: Prospective Study to Determine the Effect of Subconjunctival Bevacizumab (AVASTIN) in Corneal Neovascularization [Phase 2, Phase 3]
Prospective phase 2/3 study evaluating subconjunctival bevacizumab (Avastin) for corneal neovascularization; trial completed.
-
CLINICAL_TRIALS research · 2024-05-14Clinical Trial Update: Validation of Human Drugs Target of Repurposed Drugs and Novel Therapies
This update outlines a clinical trial on validating human drug targets for repurposed drugs and novel therapies, focusing on ocular diseases…
-
CLINICAL_TRIALS trial_result · 2021-08-18Clinical Trial Update: The Safety and Efficacy of KDR2-2 Suspension Eye Drops in the Treatment of Corneal Neovascularization [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating the safety and efficacy of KDR2-2 suspension eye drops for corneal neovascularization.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-08-10Clinical Trial Update: A Multi-Center Study of the Safety and Efficacy of Bevacizumab in High-Risk Corneal Transplant Survival [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating safety and efficacy of bevacizumab for corneal neovascularization and corneal graft failure; study compl…
-
CLINICAL_TRIALS trial_result · 2019-10-24Clinical Trial Update: Efficacy and Safety Study of Avastin to Treat Neovascularisation of the Cornea [Phase 3]
Phase 3 trial assessing efficacy and safety of Avastin for corneal neovascularization has been completed.
-
CLINICAL_TRIALS trial_result · 2017-07-11Clinical Trial Update: Ranibizumab for the Inhibition of Neovascularization in the Cornea Following Corneal Transplant Surgery [Phase 1]
Phase 1 clinical trial update evaluating ranibizumab to inhibit corneal neovascularization after corneal transplant surgery.
-
CLINICAL_TRIALS trial_result · 2017-05-15Clinical Trial Update: Safety and Efficacy of Bevacizumab in High-Risk Corneal Transplant Survival [Phase 1, Phase 2]
Bevacizumab was studied for safety and efficacy in high-risk corneal transplantation. The trial focused on corneal neovascularization and gr…
-
CLINICAL_TRIALS trial_result · 2017-05-08Clinical Trial Update: Topical IL-1-Ra for Treatment of Corneal Neovascularization [Phase 1, Phase 2]
A clinical trial evaluating a topical interleukin-1 receptor antagonist for corneal neovascularization (Phase 1/Phase 2) was terminated; res…
-
CLINICAL_TRIALS withdrawal · 2016-08-05Clinical Trial Update: Subconjunctival IVIg (Gamunex-C) Injection for Corneal Neovascularization and Inflammatory Conditions [Phase 1]
A Phase 1 trial evaluating subconjunctival intravenous immunoglobulin (Gamunex-C) for corneal neovascularization, corneal graft failure, and…
-
CLINICAL_TRIALS trial_result · 2015-10-07Clinical Trial Update: Using Aflibercept Injection to Treat Blood Vessel Growth Over the Cornea [Phase 1]
Phase 1 clinical trial evaluating aflibercept injections for corneal neovascularization has been terminated (NCT01868360).
-
CLINICAL_TRIALS withdrawal · 2015-05-01Clinical Trial Update: Corneal Thinning During Topical Bevacizumab Therapy [NA]
A clinical trial evaluating topical bevacizumab for corneal neovascularization has been withdrawn, with concerns about corneal thinning obse…
-
CLINICAL_TRIALS trial_result · 2015-03-25Clinical Trial Update: Randomized Study of Photodynamic Therapy Using Dihematoporphyrin in Patients With Corneal Neovascularization [NA]
A randomized study evaluated photodynamic therapy with dihematoporphyrin for corneal neovascularization; the trial has completed.
-
CLINICAL_TRIALS trial_result · 2013-07-03Clinical Trial Update: Effectiveness and Safety of Topical Bevacizumab (Avastin) for Treatment of Corneal Neovascularization [NA]
This trial update reports on the completed study of topical bevacizumab (Avastin) for corneal neovascularization, detailing its effectivenes…
-
CLINICAL_TRIALS trial_result · 2012-11-08Clinical Trial Update: Effectiveness and Safety of Topical Ranibizumab for Treatment of Corneal Neovascularization (NV) [Phase 1]
Phase 1 trial evaluating the effectiveness and safety of topical ranibizumab for corneal neovascularization has completed with posted result…
-
CLINICAL_TRIALS trial_result · 2012-11-06Clinical Trial Update: Treatment of Corneal Neovascularization With Topical Pazopanib [Phase 1, Phase 2]
Clinical trial updates on topical pazopanib for corneal neovascularization in Phase 1/2 completed with results posted in 2012.
-
CLINICAL_TRIALS trial_result · 2012-09-24Clinical Trial Update: Topical Avastin for Treatment of Corneal Neovascularization [Phase 1]
Phase 1 trial update on topical Avastin for corneal neovascularization has been completed with results posted.
-
CLINICAL_TRIALS trial_result · 2011-12-02Clinical Trial Update: The Effect of Bevacizumab on Corneal Neovascularization [Phase 4]
A Phase 4 clinical trial evaluated bevacizumab for corneal neovascularization and the study has completed.
-
CLINICAL_TRIALS research · 2009-10-15Clinical Trial Update: Bevacizumab for the Treatment of Corneal Neovascularization [Phase 2]
A Phase 2 study is evaluating bevacizumab for corneal neovascularization, with the trial status currently unknown.
-
CLINICAL_TRIALS trial_result · 2008-10-17Clinical Trial Update: Photodynamic Therapy With Verteporfin for Corneal Neovascularization [NA]
A clinical trial evaluating photodynamic therapy with verteporfin for corneal neovascularization has completed.
-
CLINICAL_TRIALS trial_result · 2008-05-21Clinical Trial Update: Safety and Effectiveness of Subconjunctival Injection of Bevacizumab in the Treatment of Corneal Neovasculization [NA]
A completed clinical trial evaluated the safety and effectiveness of subconjunctival bevacizumab for treating corneal neovascularization.